ACE2 and angioedema: Less available ACE2 on the cell surface due to consumption by viral entry and thus lower inactivation of bradykinin1-9 may result in increased bradykinin1-9 plasma concentrations, subsequently causing vascular leakage, angioedema, and inflammation.53